Carcinoid Syndrome: A Patient Guide
At a Glance
Carcinoid syndrome occurs when some neuroendocrine tumors release chemicals such as serotonin into the bloodstream, often after a digestive tract tumor spreads to the liver. Care combines symptom control, tumor-directed treatment, and monitoring for heart valve complications.
Carcinoid Syndrome is a complex medical condition that occurs when specific types of neuroendocrine tumors (NETs) become “functional,” meaning they begin to produce and release bioactive chemicals directly into your bloodstream [1]. While these tumors can originate in various parts of the body, most cases of the syndrome arise when a tumor in the digestive tract has spread to the liver [2]. In a healthy state, the liver acts as a filter that neutralizes these chemicals; however, when tumors take up residence in the liver, they can bypass this filter, allowing substances like serotonin to flood the general circulation [3]. It is important to know that not every functional NET causes the syndrome, and in rare cases, tumors in the lungs or ovaries can produce the syndrome without any liver metastases [3].
The experience of living with Carcinoid Syndrome is often defined by its hallmark symptoms: sudden, dry flushing of the skin and frequent, watery diarrhea [4]. These symptoms are more than just an inconvenience; they are the physical manifestation of your body reacting to a hormonal overload [5]. Because these signs often mimic more common issues like menopause or irritable bowel syndrome, many patients navigate a long journey before receiving a correct diagnosis [6]. Understanding that these episodes have a biological cause is a vital first step in regaining a sense of control over your health [1].
Managing this condition requires a strategy that addresses both the immediate symptoms and the underlying cancer, though these are not always pursued simultaneously [7]. Modern treatment plans typically evaluate blocking the release or production of hormones while also considering targeted therapies—such as surgery, surveillance, systemic therapy, or liver-directed therapy—to stabilize or reduce the size of the tumors [8]. This individualized approach is essential for protecting your long-term health, as chronic exposure to high hormone levels can lead to complications such as Carcinoid Heart Disease, which affects the heart’s valves [9].
While the diagnosis of a rare condition can feel overwhelming, the landscape of care for Carcinoid Syndrome has advanced significantly [10]. With a dedicated multidisciplinary team and a personalized management plan, it is possible to significantly reduce the impact of the syndrome on your daily life [11]. The focus of your care will always be on maintaining your quality of life and ensuring that you have the tools and information necessary to navigate this journey with confidence [12].
In this guide
6 chapters
Orientation & Validation: What is Carcinoid Syndrome?
Learn what carcinoid syndrome is, why neuroendocrine tumors cause flushing and diarrhea, who is affected, and how 5-HIAA tests and scans help confirm diagnosis.
Symptoms & Biology of Carcinoid Syndrome
Learn how carcinoid syndrome causes dry flushing, secretory diarrhea, wheezing, and abdominal pain, plus why liver spread and niacin deficiency matter.
Testing for Carcinoid Syndrome: Blood, Urine, and Scans
Learn how carcinoid syndrome is diagnosed with 5-HIAA blood or urine tests, DOTATATE PET/CT, liver MRI, and pathology results such as Ki-67 and tumor grade.
The Treatment Path: Managing Symptoms and Growth
Learn how carcinoid syndrome treatment controls flushing and diarrhea while managing tumor growth with somatostatin analogs, telotristat, PRRT, and liver therapies.
Serious Complications: Heart Health and Carcinoid Crisis
Learn how carcinoid syndrome can affect the heart, how NT-proBNP, echocardiograms, and 5-HIAA assess risk, and when a crisis requires emergency care.
Living with Carcinoid Syndrome: Daily Management & Surveillance
Learn daily carcinoid syndrome management: food triggers, nutrition and vitamin checks, stool changes, scan schedules, heart monitoring, and emotional support.
Common questions in this guide
What is carcinoid syndrome?
What are the main symptoms of carcinoid syndrome?
Does every neuroendocrine tumor cause carcinoid syndrome?
How is carcinoid syndrome treated?
Can carcinoid syndrome affect the heart?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my current symptom profile suggest that my neuroendocrine tumor is 'functioning' and releasing hormones?
- 2.What specific hormone tests and imaging will we use to confirm this diagnosis?
- 3.How will we balance treating my daily symptoms, like flushing and diarrhea, with treating the tumor itself?
- 4.What steps will we take to monitor my heart health and prevent long-term complications?
- 5.Are there specific lifestyle or dietary triggers I should avoid while we begin my treatment plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Carcinoid Syndrome: A Review.
Gade AK, Olariu E, Douthit NT
Cureus 2020; (12(3)):e7186 doi:10.7759/cureus.7186.
PMID: 32257725 - 2
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.
Mulders MCF, de Herder WW, Hofland J
Endocrine reviews 2024; (45(3)):351-360 doi:10.1210/endrev/bnad035.
PMID: 38038364 - 3
Primary Ovarian Neuroendocrine Neoplasm With Carcinoid Syndrome and Carcinoid Heart Disease.
Thammakosol K, Vathesatogkit P, Leelasithorn S, Sriphrapradang C
Ochsner journal 2026; (26(2)):173-178 doi:10.31486/toj.25.0101.
PMID: 42311579 - 4
Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease: A Retrospective Multicentric Study of 276 Patients.
Fijalkowski R, Reher D, Rinke A, et al.
Neuroendocrinology 2022; (112(6)):547-554 doi:10.1159/000518651.
PMID: 34348326 - 5
Updates on the biology of serotonin and tryptophan hydroxylase.
Swami T, Weber HC
Current opinion in endocrinology, diabetes, and obesity 2018; (25(1)):12-21 doi:10.1097/MED.0000000000000383.
PMID: 29194046 - 6
Carcinoid syndrome mimicking irritable bowel syndrome: don't fall into the trap.
Massironi S, Gallo C, Franchina M, et al.
Expert review of gastroenterology & hepatology 2025; (19(10)):1119-1132 doi:10.1080/17474124.2025.2557245.
PMID: 40902188 - 7
Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.
Pokuri VK, Fong MK, Iyer R
Current oncology reports 2016; (18(1)):7 doi:10.1007/s11912-015-0492-7.
PMID: 26743514 - 8
Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome.
Koumarianou A, Daskalakis K, Tsoli M, et al.
Journal of neuroendocrinology 2022; (34(7)):e13174 doi:10.1111/jne.13174.
PMID: 35794780 - 9
Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
Das S, Stockton SS, Hassan SA
The oncologist 2023; (28(7)):575-583 doi:10.1093/oncolo/oyad126.
PMID: 37209415 - 10
Management of carcinoid syndrome: a systematic review and meta-analysis.
Hofland J, Herrera-Martínez AD, Zandee WT, de Herder WW
Endocrine-related cancer 2019; (26(3)):R145-R156.
PMID: 30608900 - 11
TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.
Strosberg J, Joish VN, Giacalone S, et al.
The oncologist 2019; (24(11)):1446-1452 doi:10.1634/theoncologist.2018-0921.
PMID: 31189618 - 12
Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.
Algeri L, Falkman L, Spada F, et al.
ESMO open 2024; (9(11)):103959 doi:10.1016/j.esmoop.2024.103959.
PMID: 39442478
This page is for informational purposes only and does not constitute medical advice. Discuss your symptoms, tumor treatment, and heart monitoring plan with your oncology team.
Get notified when new evidence is published on Carcinoid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.